StockTipsArenaBeta

BUY Tatva Chintan Pharma Chem Limited — ICICI Securities

BUYTatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)22 Jan 2026via Institutional / Brokerage Research

Entry₹1,273.2Inferred
Target₹1,955
Total upside +53.55% (call closed)
Stop lossNot given
Exit₹1,9557 Oct 2026, 10:25 am
Target hit+53.55%0.00%upside left
Follow ICICI Securities for new calls(67% target hit, 1026 closed calls)Get alertsWatch TATVA for new buy/sell callsGet alertsSee 1 active Long-term call on TATVASee 212 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 7 Oct 2026
4 supporting5 neutral0 opposing
Supports the BUY call (4)

Tatva Chintan Pharma Chem (NSE:TATVA) Investor Meeting and Q1 FY27 Recovery Update

NewsGoogle News·18 Sept · 3w ago

(opens in new tab)

CRISIL Ratings has upgraded Tatva Chintan Pharma Chem Ltd's long-term rating from BBB+/Stable to A-/Stable and short-term rating from A2 to A2+.

BSE · Company Update·8 Sept · 4w ago

(opens in new tab)
Neutral / worth noting (5)

Tatva Chintan Pharma Chem TATVA Trading Window Closure

NewsGoogle News·23 Sept · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Tatva Chintan Pharma Chem

All analyst calls on Tatva Chintan Pharma Chem

More from ICICI Securities

Every call and its outcome